Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
decline in cognitive functions and associated with the neuropathological hallmarks of …

An early feature of Alzheimer's disease (AD) is region-specific declines in brain glucose
metabolism. Unlike other tissues in the body, the brain does not efficiently metabolize fats; …

At present, the prevalence of Alzheimer's disease, a devastating neurodegenerative
disorder, is increasing. Although the mechanism of the underlying pathology is not fully …

Introduction Alzheimer's disease (AD) is a progressive neurodegenerative disease that is
the most common form of dementia. There are currently FDA-approved symptomatic …

Background Brain amyloid deposition and neurofibrillary tangles in Alzheimer's disease
(AD) are associated with complex neuroinflammatory reactions such as microglial activation …

The prevalence of Alzheimer's disease, a chronic neurodegenerative condition, is
increasing as is the need for effective treatments and preventions. The underlying pathology …

Background Brain energy metabolism is impaired in Alzheimer's disease (AD), which may
be mitigated by a ketogenic diet. We conducted a randomized crossover trial to determine …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is mainly
characterized by cognitive deficits. Although many studies have been devoted to developing …

The goal of this review was to assess the effectiveness of ketogenic diets on the therapy of
neurodegenerative diseases. The ketogenic diet is a low-carbohydrate and fat-rich diet. Its …

Dementia (major neurocognitive disorder) is an increasingly common syndrome with a
significant burden on patients, caregivers, the health-care system, and the society. The …